article thumbnail

Gaining Market Access in Emerging Markets – Take Action!

Clarity Engagement Solutions

The process of approval was simple: once the data showed the efficacy, safety and reliability to the regulatory agencies, the drug was approved. A survey conducted by Cegedim revealed that Key Account Management (KAM) was the technique that procured the best results for market access strategies.

article thumbnail

Gaining Market Access in Emerging Markets – Take Action!

Clarity Engagement Solutions

The process of approval was simple: once the data showed the efficacy, safety and reliability to the regulatory agencies, the drug was approved. A survey conducted by Cegedim revealed that Key Account Management (KAM) was the technique that procured the best results for market access strategies. – Channel.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How the Ukrainian clinical trial industry is overcoming disruption

Pharmaceutical Technology

Requirements on imports, packaging, storage and circulation of medical products and devices have been eased, while continuing to uphold product requirements for efficacy and patient safety. The clinical trial map is starting to reconfigure around a new normality. The clinical trial map is starting to reconfigure around a new normality.

article thumbnail

Quality first: How pharma can meet injectables demand while staying compliant

Pharmaceutical Technology

According to Barbara Santambrogio, Quality Key Account Manager at leading elastomer component manufacturer Datwyler, another significant regulatory trend is the importance of evaluating complete drug delivery systems rather than individual components.

Pharma 52
article thumbnail

Clinical trials in Ukraine: Ensuring supply chain continuity during war

Pharmaceutical Technology

Little by little, clinical trials are coming back to Ukraine,” suggests Pawel Drozd, senior key account manager for clinical trial logistics at Oximio. Oncology remains the highest indication area with eight trials, with ophthalmology next at six. Credit: Oximio.